SCHEMBL526891

SCHEMBL526891

CC(=O)CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15043693 1.00 LIPA (0.38)
SCHEMBL14576723 1.00 LIPA (0.38)
SCHEMBL15043694 0.92 KMT2A (0.40)
SCHEMBL10174290 0.89 NAMPT (0.36)
SCHEMBL15445405 0.89 ANPEP (0.47)
SCHEMBL12424289 0.89 ESR1 (0.33)
SCHEMBL15067035 0.89 EPHX2 (0.36)
SCHEMBL156237 0.88
SCHEMBL1396131 0.88
SCHEMBL23168695 0.87 PLG (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051854-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS D.D. (SI) 2014-02-20 US claimed
EP-2598484-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK Pharmaceuticals d.d. (SI) 2013-06-05 EP claimed
CN-103119022-A Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof LEK PHARMACEUTICALS 2013-05-22 CN claimed
EP-2423195-A1 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof LEK Pharmaceuticals d.d. (SI) 2012-02-29 EP claimed
WO-2012013325-A1 PROCESS FOR THE PREPARATION OF KEY INTERMEDIATES FOR THE SYNTHESIS OF STATINS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF LEK PHARMACEUTICALS D.D. (SI) 2012-02-02 WO claimed
US-20250326769-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT INC (US) 2025-10-23 US disclosed
EP-4605397-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS Nuvalent, Inc. (US) 2025-08-27 EP disclosed
US-12358887-B2 IKAROS Zinc Finger Family degraders and uses thereof GILEAD SCIENCES, INC. (US) 2025-07-15 US disclosed
WO-2025035759-A1 KIF18A INHIBITOR AND USE THEREOF 深圳市祥根生物有限公司 2025-02-20 WO disclosed
EP-4464703-A2 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF Gilead Sciences, Inc. (US) 2024-11-20 EP disclosed
EP-4245756-B1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES INC (US) 2024-10-09 EP disclosed
CN-118725980-A Refining method of coffee essential oil 杭州佳嘉乐生物技术有限公司 2024-10-01 CN disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed
US-4960779-A Pyrrole derivatives, and pharmaceutical compositions which contain them and pharmacological methods of use RHONE-POULENC SANTE (FR) 1990-10-02 US disclosed
EP-0351649-A2 2,2-Dihalocyclopropyl-hydroxy-ethyl triazoles BAYER AG (DE) 1990-01-24 EP disclosed
EP-0351647-A2 2,2-Difluorocyclopropyl derivates BAYER AG (DE) 1990-01-24 EP disclosed
EP-0080102-A1 Cycloalkyl-(alpha-triazolyl-beta-hydroxy) ketones, process for their preparation and their use as fungicides and plant growth regulators BAYER AG (DE) 1983-06-01 EP disclosed
EP-0002850-B1 NOVEL INTERMEDIATES IN THE PREPARATION OF CYCLOPROPYLCARBOXYLATE ESTERS AND PROCESS FOR THEIR MANUFACTURE SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1982-02-17 EP disclosed
US-4247711-A CHEMICAL INTERMEDIATES FOR PYRETHRUM PESTICIDES SHELL OIL COMPANY (US) 1981-01-27 US disclosed
US-4093622-A Pyridine esters of cyclopropane-carboxylic acid ZOECON CORPORATION (US) 1978-06-06 US disclosed